Background: Phagocytosis assays are traditionally performed in vitro using polymorphonuclear leukocytes (PMNs) isolated from peripheral blood or the peritoneum and heat-killed, preopsonized organisms. These assays may not adequately mimic the environment within the infected lung. Our laboratory therefore has developed a flow cytometric in vivo phagocytosis assay that enables quantification of PMN phagocytosis of viable bacteria within the lungs of rats. In these studies, rats are injected transtracheally with lipopolysaccharide (LPS) to recruit PMNs to their lungs. They are then infected with live 5(-and 6) carboxyfluorescein diacetate succinimidyl ester (CFDA/SE) labeled type 3 Streptococcus pneumoniae. Bronchoalveolar lavage is performed and resident alveolar macrophages and recruited PMNs are labeled with monoclonal antibodies specific for surface epitopes on each cell type. Three color flow cytometry is utilized to identify the cell types, quantify recruitment, and determine uptake of the labeled bacteria.
Introduction
Phagocytosis and killing of pathogens by resident alveolar macrophages and recruited polymorphonuclear leuckocytes (PMNs) is integral in clearing bacterial respiratory tract infections. Because alveolar macrophages (AM) do not efficiently phagocytose most strains of Streptococcus pneumoniae (the pneumococcus), uptake and killing by recruited PMNs is particularly important during pneumococcal pneumonia [1] . For a number of years, our labora-tory has been studying the effects of ethanol ingestion and liver disease on pulmonary PMN function. We began with traditional phagocytosis assays performed in vitro with peripheral or peritoneal PMNs and heat-killed, preopsonized organisms. Such assays are limited, however, in that they cannot adequately mimic the conditions present within the infected lung. Therefore, they may not detect all host defects leading to reduced phagocytic uptake of bacteria during pulmonary infections.
One particular difficulty with the use of in vitro assays for measurement of pneumococcal phagocytosis is that the organisms are not taken up unless they are pre-opsonized with serum containing active complement components, even though the serum may contain high titers of specific antipneumococcal antibodies [2] . This need for preopsonization of the organisms makes it impossible to examine certain underlying host immune defects such as complement deficiencies. The serotype 3 pneumococcal strain used in our studies (ATCC 6303) presents an additional unique difficulty when used in in vitro phagocytosis assays because neither human nor rat PMNs phagocytose this highly encapsulated S. pneumoniae strain in vitro [2] [3] [4] . The type 3 strain's ability to avoid phagocytosis in vitro has been hypothesized to be the result of its large capsule that precludes accessibility of its complement and immunoglobulin receptors [3] .
Several years ago our laboratory developed an in vivo phagocytosis assay that utilized flow cytometry and type 3 pneumococci labeled with Lucifer Yellow [2] . Although a major improvement, this assay still was not physiologically relevant to the infection process because Lucifer Yellow is excluded by live bacteria. This necessitated heatkilling of the bacteria, a process that can alter the pathogen's surface and impair the function of its anti-phagocytic capsule. To overcome this limitation of our original in vivo assay, we now have created an in vivo phagocytosis assay that utilizes live type 3 pneumococci and 3-color flow cytometry. This assay allows for the measurement of phagocytosis of live, non-opsonized S. pneumoniae within the natural environment of the lung, enabling us to effectively mimic the events that occur during an actual pneumococcal infection. This manuscript describes and validates our assay and demonstrates its potential for adaptation to other microorganisms and animal models of infection.
Results

Fluorescent labeling of bacteria and bacterial viability
To confirm that the S. pneumoniae organisms were adequately labeled, flow cytometry was performed. Figure 1 shows that the bacteria effectively took up the CFDA/SE and fluoresced brightly. To determine if our assay could be utilized for the measurement of in vivo phagocytosis of other bacterial organisms, we attempted to CFSE label Escherichia coli and Staphylococcus aureus as well. Using the protocol described in this paper, CFSE did not effectively label E. coli organisms (data not shown). On the other hand, S. aureus was labeled by CFSE, although the organisms fluoresced at nearly a log lower intensity than S. pneumoniae organisms ( Figure 2 ). The CFSE staining protocol did not affect the viability of any of the organisms (Table 1) .
Flow cytometric analysis of BAL cells
To exclude autofluorescence of the PMN and macrophage populations, a sample of BAL cells from a control animal infected with live, but non-fluorescent S. pneumoniae was used to calibrate the machine each day the assay was run. Figure 3A shows the PMN population from one representative control animal. Figure 3B is a representative dot plot of a test animal infected with CFSE-labeled pneumococci. The percentage of RP-1-positive cells (PMNs, Figure 3A ) or 1C7-positive cells (macrophages, data not shown) that had taken up the CFSE-labeled pneumococci was then determined ( Figure 3B ).
Confocal microscopy of BAL cells
Confocal microscopy was performed to ensure that the pneumococci were phagocytosed by the recruited PMNs, not just adherent to the cell surface. Figure 4 shows the confocal (4A) and phase overlay (4B) images of internalized pneumococci.
Stability of CFSE labeling of pneumococci
To ensure that our results were not due to release of the CFSE label during incubation of the pneumococci in the rats' lungs and subsequent uptake of CFSE by the PMNs, CFSE-labeled pneumococci were incubated at 37°C for 1 h in fresh BAL fluid. The bacteria were then removed by centrifugation and the resulting supernatant was incubated with BAL cells. Figure 5 shows an overlay image of the lavage cells before (gray shading) and after (black line) incubation with the supernatant showing a negligible shift in the cells' fluorescence.
Verification by light microscopy of PMN recruitment values
To validate our flow cytometric assay, we compared manual counts of cytospin slides to the flow cytometric data. Viability of the collected BAL cells was consistently >95%. Cytospin preparations stained with Protocol Hema-3 were used to classify 200 cells in each sample based on their morphological characteristics. The percentages of macrophages and PMNs counted on the microscope slides were quite similar to those determined by flow cytometry. A comparison of the PMN values for ten representative animals is shown in Table 2 . For all 31 rats examined, the mean percent ± S.E.M. PMN recruitment determined by flow cytometry was 70.9 ± 2.5, whereas the mean determined by manual counts was 66.6 ± 1.9. The correlation coefficient between the values measured by the two methods was 0.488 (p < 0.006). The percentage of macrophages present in each sample also correlated well between the two methods of measurement with a correlation coefficient of 0.578 (p < 0.0001).
Verification of phagocytosis values by light microscopy
Manual counts of cytospin slides prepared from each rat also were used to verify the percentage of macrophage and PMN phagocytosis measured by flow cytometry. A minimum of 200 cells were counted in the light microscope to quantify the percentage of each cell population that con- Table 3 . For all 31 rats examined, the mean percent ± S.E.M. PMN phagocy-tosis determined by flow cytometry was 16.1 ± 1.4, whereas the mean determined by manual counts was 18.7 ± 1.7. The correlation coefficient for the values determined by the two methods was 0.688 (p < 0.0002). Con- 
Determination of percentage of PMNs with internalized bacteria
Discussion
This manuscript describes an immunological assay to measure PMN recruitment and phagocytosis of viable type 3 Streptococcus pneumoniae within the lungs of rats rather than the artificial environment used for in vitro assays. Performing the experiment within the rats' lungs allows the simultaneous measurement of recruitment and phagocytosis and precludes the necessity for pre-opsonization of the organisms. One can therefore examine host defects in opsonic capacity as well as phagocyte function. The ability to utilize live bacteria is a major improvement over our earlier in vivo assay [2] because it allows for quantification of phagocytic uptake of organisms that are physiologically relevant to those found during an actual pulmonary infection.
One early difficulty in development of the assay was finding a dye that could enter live S. pneumoniae and then remain stable within the bacteria rather than leaking out where it could be taken up by the phagocytes to give false positive readings. The dye CFDA/SE fulfilled these requirements; in its' nonfluorescent form it readily enters live bacteria where the acetate groups are cleaved by cytosolic esterases [5] . The CFSE molecule is stable within
Stability of CFSE Labeling of Pneumococci Figure 5
Stability of CFSE Labeling of Pneumococci. To ensure that CFSE did not leak out of labeled pneumococci when they were in the rats' lungs, CFSE labeled pneumococci were incubated with fresh lavage fluid. After centrifugation to remove the bacteria the supernatant was incubated with lavage cells. Lavage cells before incubation with the supernatant (gray shading) and after (black line).
Phase contrast microscopy (A) was used to demonstrate the presence of the bacteria within the pulmonary cells and an over-lay technique (B) was used to show that the bacteria were internalized Figure 4 Phase contrast microscopy (A) was used to demonstrate the presence of the bacteria within the pulmonary cells and an overlay technique (B) was used to show that the bacteria were internalized.
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the bacterial cell, and does not leak out in appreciable amounts, even when the pneumococci are allowed to divide.
Our CFSE staining protocol effectively labeled S. aureus organisms, but not E. coli. It may be that the gram negative organism is either less permeable to the CFSE molecule or able to pump it out of the cytoplasm (as is evidenced with certain antibiotics). Therefore, the described in vivo phagocytosis assay may only be useful for certain organisms and not others. However, alternative fluorescent dyes may be substituted for CFSE in our assay.
As expected, few alveolar macrophages were shown to internalize pneumococci when examined by light microscopy. Unlike the PMN phagocytosis values, there was no agreement or even correlation between the flow cytometric and light microscopy values for the alveolar macrophage population. The reason for the artificially high phagocytosis values by flow cytometry is the intrinsically high autofluorescence of rat macrophage populations [6] . This autofluorescence is at the same wavelength as the CFSE fluorescence, thus precluding accurate measurement of the macrophage phagocytosis. Pneumococci in general and the type 3 strain in particular are known to resist phagocytosis by macrophages [1] . For this reason we optimized our assay for measuring recruitment and phagocytosis of the PMN rather than the macrophage. In order to utilize this assay for the measurement of macrophage phagocytosis of other bacterial strains, it will be important to make several adjustments to this protocol, which may include using an alternate fluorochrome to label the organism and/or a different anti-macrophage antibody.
The high degree of correlation between PMN phagocytosis as determined by flow cytometry and the much more subjective and labor intensive manual counting of cytospin slides validates the flow cytometric method. As with all phagocytosis assays, however, there is concern about the ability to differentiate ingested organisms from those bound to the outside of the phagocytes [7] [8] [9] . Traditionally, differentiation of bound but not internalized organisms has been accomplished through the addition of a quenching agent such as ethidium bromide or trypan blue that eliminates fluorescence of bound, but not internalized organisms [7, 8, 10] . In our assay, using these agents to quench externally bound organisms is not an option because live S. pneumoniae exclude these quenching agents. In addition, the monoclonal antibodies used to identify the PMN and macrophage populations bind to surface epitopes on the cells, and the addition of a quenching agent may remove this fluorescence as well. We therefore utilized confocal microscopy to confirm that the organisms are located within the cell membrane rather than bound to the surface of the cells. 
Conclusion
The novel in vivo phagocytosis assay described in this manuscript provides a unique opportunity to "visualize" what is occurring within the lungs during an actual infection and to measure several aspects of host defense against pulmonary pathogens. Although the method has been optimized for use with pneumococcal phagocytosis by PMNs in rat lungs, the methods described can well be adapted to measure pulmonary uptake of other microorganisms in alternative animal models as well.
Methods
Animals
Male Sprague-Dawley rats (Charles River Laboratories, Kingston, NY) weighing 350-400 g were used. All experimental procedures described herein were approved by the Animal Studies Subcommittee, both at Creighton University and the Omaha Veterans Affairs Medical Center.
Streptococcus pneumoniae growth and labeling conditions
The organism used for the phagocytosis assay was a type 3 S. pneumoniae (ATCC 6303; American Type Culture Collection, Rockville, Maryland, USA) that was originally a clinical isolate. It was stored at -80°C in Todd-Hewitt Broth containing 10% glycerol. Before each experiment, the bacteria were grown to mid-log phase in Todd-Hewitt broth supplemented with 5% heat-inactivated rabbit serum (Nieffengger Company, Woodland, CA). They were collected by centrifugation at 10,000 × g for 10 minutes, washed twice with phosphate buffered saline (PBS), and resuspended in PBS to an optical density of 1.0 at 540 nm. An aliquot of the suspension then was incubated at 37°C for 30 min in the dark with an equal volume of a 2.0 μM solution of 5(-and 6) carboxyfluorescein diacetate succinimidyl ester (CFDA/SE, Molecular Probes, Eugene, Oregon), the non-fluorescent diacetate form of CFDA that easily passes through cell membranes to label viable bac-teria [5] . Once inside the organisms, the molecule is converted to the fluorescent form known as CFSE [5(-and 6) carboxyfluorescein succinimidyl ester].
After washing three times with PBS to remove excess dye, the bacteria were once again resuspended in PBS to an optical density of 2.5 at 540 nm (equivalent to 3 × 10 9 colony forming units (cfu)/ml). To ensure that viability of the pneumococci was not altered by CFSE labeling, aliquots of a suspension of S. pneumoniae organisms (O.D. 1.0 at 540 nm) were serially diluted on sheep blood agar plates before and after staining.
Flow cytometry of bacteria
Flow cytometry of bacteria was performed using standard methods for bacterial analysis by flow cytometry. Briefly, forward scatter, side scatter, and all fluorescence parameters were collected in log mode. Instrument thresholding was performed on either side and/or forward scatter signals. CFSE fluorescence was detected on the FACSCalibur (Becton Dickinson, San Jose, CA) using a 530/30 bandpass filter.
Labeling of other bacterial strains
Escherichia coli (ATCC25922) and Staphylococcus aureus (ATCC25923) were grown overnight on blood agar plates, and then resuspended in PBS to an optical density of 1.0 at 540 nm. An aliquot of the bacterial suspensions were plated on sheep's blood agar plates to enumerate the colony forming units before staining. Equal volumes of each bacterial strain were incubated with CFSE as described above for S. pneumoniae. The bacterial strains were then washed twice with PBS and resuspended to an optical density of 1.0 at 540 nm. An aliquot of the bacterial suspensions were once again plated to determine the effect of CFSE labeling on bacterial viability. Flow cytometry was performed on fixed samples of the E. coli and S. aureus organisms as described above. 
